UMIN-CTR History

BACK TOP
UMIN-CTR English Home Glossary (Simple) FAQ Search clinical trials

Name:
UMIN ID:

Unique ID issued by UMIN UMIN000030372
Receipt No. R000034675
Scientific Title Phase II study of ramucirumab and irinotecan combination therapy as second-line treatment in patients with metastatic or advanced gastric cancer
Date of disclosure of the study information 2017/12/13
Last modified on 2019/10/06 00:36:04

No. Disposal Last modified on Item of update
1 Insert 2017/12/13 01:24:03
2 Update 2018/06/14 23:49:38 Recruitment status
3 Update 2018/12/15 22:58:32 Division name
4 Update 2019/10/06 00:33:43 1st name of lead principal investigator
Last name of lead principal investigator
1st name of lead principal investigator
Last name of lead principal investigator
Zip code

Last name of contact person

Last name of contact person
Zip code
Email3
Organization
Organization
Address
Address
Tel
Email
5 Update 2019/10/06 00:36:04 Recruitment status
Date of IRB
Last follow-up date


Contact us.